GVK Bio-sciences, Hyderabad
- Screening of NCEs for anti-cancer activity using in vivo xenograft models
- Re-purposing of various NCEs molecules for prevention/treatment of Pulmonary Arterial Hypertension (PAH)
The in vitro and in vivo studies established the proof of mechanism, that the armoury of polyphenols in combination, potentially abrogates CD36 signalling mediated pathogenic foam cell formation and promote their emigration from the intima resulted in atheroinflammatory lesion regression.
Pharmacological mechanistic anti-asthmatic and antianaphylactic activities of a homeopathic drug - B. orientalis were established for the first time. The thermoreversible (PF-127) nasal gel of B. orientalis were formulated which showed better anti-asthmatic activity.
Dr. J. B. Gupta, Chief Scientific Officer
GVK Biosciences Private Limited, Hyderabad: 500 076, India
Email ID: email@example.com
Dr. B. Dinesh Kumar, PhD, FAPASc, FIPS
Scientist ‘F’ (Deputi Director - Sr.) and PCT-Coordinator
Center for Advanced Research for Preclinical Toxicology Center
Food and Drug Toxicology Research Center
National Institute of Nutrition (ICMR), Govt. of India, Hyderabad, 500 007, India.
T: +91 (040) 27197322, M: +91 9849082088
Dr. B. Sesikeran, MD, FNAMS, FAPASc
Former Director-National Institute of Nutrition, ICMR
Guest Faculty University of Hyderabad
Chairman- Scientific Panel- FSSAI, Hyderabad, 500 007, India.
M: +91-9849081993, R: +91 -40-27173055